Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
Sionna Therapeutics, Inc. (SION) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sionna Therapeutics, Inc. (SION) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Earnings Preview: Morgan Stanley to Report This Week
Big banks are kicking off earnings season this week, with JPMorgan Chase (JPM) weighing on the market today.
BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
BeOne Medicines AG (ONC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
CeriBell, Inc. (CBLL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Telix Pharmaceuticals Limited (TLX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Telix Pharmaceuticals Limited (TLX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Kinder Morgan: Quietly Doing Everything Right
Kinder Morgan (KMI) remains a high-quality midstream operator with a reaffirmed 'buy' rating due to consistent growth, stable fundamentals, and prudent capital allocation. KMI's net leverage ratio is declining, projected to reach 3.80 by 2026, signaling a lower risk profile and increased financial flexibility versus peers. Dividend growth remains steady, with the 2024 yield at 4.26% and a ninth consecutive annual increase expected, supported by robust cash flows and disciplined payout ratios.
Morgan Stanley Direct Lending Is In Trouble (Rating Downgrade)
Morgan Stanley Direct Lending Fund's weighted average yield fell from 11% in Q3 2024 to 9.9% in Q3 2025, pressuring NII, but that's not my largest concern. MSDL is in trouble because of increasing struggles of its portfolio companies. Is it time to stop buying MSDL? I think so - I've stopped reinvesting as MSDL's portfolio performs in the opposite direction it should.
Morgan Stanley's Top Software Pick for 2026 is a Great Value Buy
Sometimes, the best value picks are the ones that have been hiding in plain sight all along.
Morgan Stanley Joins Wall Street Peers in Embracing Crypto
Morgan Stanley is reportedly entering the cryptocurrency exchange-traded fund (ETF) space. The Wall Street bank has submitted paperwork for a Bitcoin Trust and a Solana Trust, each of which would hold the individual cryptocurrencies, Bloomberg news reported Tuesday (Jan. 6), citing a regulatory filing.
JP Morgan expects solid AstraZeneca quarter and reassuring outlook
AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is set to deliver a solid finish to 2025 when it reports fourth-quarter results next month, according to JP Morgan, which expects earnings to come in modestly ahead of market expectations and guidance for 2026 to underpin confidence in the growth outlook. The US bank forecasts fourth-quarter revenues of $15.5 billion, representing 2% growth at constant exchange rates and about 1% ahead of consensus forecasts.
Passive Income Dividend Giants Dominate JP Morgan's 2026 Energy Top Picks
As the calendar turns to 2026, the leading Wall Street firms are releasing their top stock picks for the new year.
Morgan Stanley Direct Lending: Continues To Disappoint Going Into 2026
Morgan Stanley Direct Lending Fund (MSDL) remains a sell as persistent NAV deterioration and thin dividend coverage signal elevated risk. MSDL trades at a 16.85% discount to NAV, reflecting portfolio headwinds rather than a value opportunity. Net investment income barely covers the 11.8% yield, with rising non-accruals and limited new investment activity constraining growth.
